Microfracturing with Chondro-Gide® for the treament of isolated cartilage defects in the knee - long-term results of a randomized study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040520

Enrollment

Registered

2026-06-22

Start date

2020-06-29

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M24.1

Interventions

Group 1: Microfracture (MFx) alone Group 2: glued AMIC® (MFx + Chondro-Gide®) Group 3: sutured AMIC® (MFx + Chondro-Gide®)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients who received one of the aforementioned treatment modalities on the knee joint at least 15 years ago as part of the randomized controlled study at the two participating study centers.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
By means of patient surveys, clinical follow-up examinations, and MRI assessments, this follow-up study aims to comparatively evaluate the long-term treatment outcomes of these procedures after at least 15–20 years.	—

Countries

Germany

Contacts

Public ContactThomas Schönberger

Orthopädische Klinik für die Universität Regensburg Im Asklepios Klinikum Bad Abbach

t.schoenberger@asklepios.com+49 94 05 18 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026